SAN FRANCISCO, Jan. 30, 2024 /PRNewswire/ -- Invitae(NYSE: NVTA), a leading medical genetics company, today announced a partnership with BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, designed to advance genetics-based drug discovery for rare diseases. The goal of the collaboration is to generate new insights focused on genetic modifiers and the discovery of novel therapeutic targets for rare diseases and other unmet medical needs.
The agreement expands upon the longstanding partnership between the two companies to combine the strengths of BridgeBio's deep expertise in rare disease research and development of therapeutics, and Invitae's rare disease enriched dataset and analytical capabilities. Invitae has provided clinical testing for more than 4 million patients, generating an extensive dataset that is uniquely positioned to deepen insights on patients with genetic-driven disease.
"Invitae is on a mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. By leveraging de-identified genetic information from patients, our researchers can gain a much deeper understanding of the genetic basis of a disease," said W. Michael Korn, M.D., chief medical officer at Invitae. "Through this partnership, we aim to support the development of novel therapeutic targets and advance transformative medicines for patients with rare disease."
Access to large genetic and clinical datasets are needed to advance research and discover novel drug targets and are often hard to find for researchers.
"We chose to partner with Invitae because of the unique scale and depth of their dataset on affected populations. Patients with severe and highly penetrant dominant disorders are not represented in general population studies, making it nearly impossible to find data anywhere except a disease-focused cohort like Invitae's," said Sun-Gou Ji, Ph.D., vice president of computational genetics at BridgeBio. "These rich data sources will continue to offer researchers a mechanism to get a much deeper understanding of genetic variations and their effect on diseases."
Together Invitae and BridgeBio will translate genetic and phenotypic data into insights to improve therapeutic discovery and design for patients with rare disease. Invitae will analyze longitudinal medical phenotypes in linked genetic and clinical datasets, in order to understand the burden of disease in a real-world setting. Harnessing BridgeBio's disease expertise, Invitae will leverage AI-based phenotypic clustering to identify subgroups of patients based on their genetic and phenotypic profiles. Invitae will also conduct association testing to identify potential genetic modifiers of disease phenotype, severity, onset and progression.
For more information about Invitae's solutions for biopharma partners, visit https://www.invitae.com/en/partners/biopharma.
About InvitaeInvitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We aim to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.
To learn more, visit invitae.comand follow for updates on Twitter, Instagram, Facebook and LinkedIn@Invitae.
About BridgeBioBridgeBio is a biotechnology company on a mission to discover and deliver transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.
Safe Harbor StatementThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relatingto the company's goals with respect to the partnership; the intended structure and potential benefits of the partnership; the company's beliefs regarding its dataset and analytical capabilities; and the company's belief that the partnership may support the development of novel therapeutic targets and advance transformative medicines for patients with rare disease. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: the company's ability to grow its business in a cost-efficient manner; the company's history of losses; the company's ability to maintain important customer relationships; the company's ability to compete; the company's need to scale its infrastructure in advance of demand for its tests and to increase demand for its tests; the risk that the company may not obtain or maintain sufficient levels of reimbursement for its tests; the applicability of clinical results to actual outcomes; risks associated with litigation; the company's ability to use rapidly changing genetic data to interpret test results accurately and consistently; security breaches, loss of data and other disruptions; laws and regulations applicable to the company's business; and the other risks set forth in the company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023. These forward-looking statements speak only as of the date hereof, and Invitae Corporation disclaims any obligation to update these forward-looking statements.
Invitae PR contact:Renee Kelley [emailprotected]
SOURCE Invitae Corporation
Go here to see the original:
Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics - PR Newswire
- Scientists Unveil the Genetic Blueprint of Blood Pressure - SciTechDaily - May 12th, 2024 [May 12th, 2024]
- Analysis | An NIH genetics study targets a long-standing challenge: Diversity - The Washington Post - May 12th, 2024 [May 12th, 2024]
- NSF grant to fund research on genetics and physiology of corn kernel development - Penn State University - May 12th, 2024 [May 12th, 2024]
- Honey Creek Beef farm's success spurred by focus on animal comfort, genetics and feed - Dayton Daily News - May 12th, 2024 [May 12th, 2024]
- Deciphering genetic diversity in conserved cattle bulls to achieve sustainable development goals | Scientific Reports - Nature.com - May 12th, 2024 [May 12th, 2024]
- Research finds genetics plays bigger role in Alzheimer's than previously thought - CBS Boston - May 12th, 2024 [May 12th, 2024]
- Kids Shape Their Development to Match Genetic Tendencies - Neuroscience News - May 12th, 2024 [May 12th, 2024]
- Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year ... - Yahoo Finance - May 12th, 2024 [May 12th, 2024]
- Navigating the Complexities of Payment for Genetic Testing - MedCity News - May 12th, 2024 [May 12th, 2024]
- CSHLs Gabrielle Pouchelon studies effects of sensory cues, genetics on brain development - TBR News Media - May 12th, 2024 [May 12th, 2024]
- Puberty Growth Spurts Linked to Adult Health Risks - Neuroscience News - May 12th, 2024 [May 12th, 2024]
- Liberty Hill Farm Holds Auction of Elite Genetics - ourherald.com - May 12th, 2024 [May 12th, 2024]
- CRISPR gene-editing therapies need more diverse DNA to realize their full potential - Vox.com - May 12th, 2024 [May 12th, 2024]
- An epigenome editing toolkit to dissect the mechanisms of gene regulation - EurekAlert - May 12th, 2024 [May 12th, 2024]
- Introgression and disruption of migration routes have shaped the genetic integrity of wildebeest populations - Nature.com - April 15th, 2024 [April 15th, 2024]
- Is Left-Handedness Tied to Your Genetics? Possibly, New Study Suggests - Technology Networks - April 15th, 2024 [April 15th, 2024]
- A pan-genome of 69 Arabidopsis thaliana accessions reveals a conserved genome structure throughout the global ... - Nature.com - April 15th, 2024 [April 15th, 2024]
- Clemson researchers pave the way for precision medicine with AI - Clemson News - April 15th, 2024 [April 15th, 2024]
- ACMG Foundation for Genetic and Genomic Medicine Elects Four Highly Accomplished Medical Genetics ... - PR Newswire - April 15th, 2024 [April 15th, 2024]
- Katie Gallagher MS '15, CGC Named Director of the Joan H. Marks Graduate Program in Human Genetics at Sarah ... - Sarah Lawrence College - April 15th, 2024 [April 15th, 2024]
- The genomic architecture of inherited DNA variants - Baylor College of Medicine | BCM - April 15th, 2024 [April 15th, 2024]
- Clemson genetics major named Truman Scholar for her work in combatting rare diseases - ABC NEWS 4 - April 15th, 2024 [April 15th, 2024]
- Otago University Discovers Cause of Rare Genetic Condition - Mirage News - April 15th, 2024 [April 15th, 2024]
- Genetic Analysis Guides Conservation of Endangered Bumble Bee - Entomology Today - April 15th, 2024 [April 15th, 2024]
- First insights into the genetic bottleneck characterizing early sheep husbandry in the Neolithic period - EurekAlert - April 15th, 2024 [April 15th, 2024]
- Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease - Nature.com - April 7th, 2024 [April 7th, 2024]
- A deep dive into the genetics of alcohol consumption - Medical Xpress - April 7th, 2024 [April 7th, 2024]
- Right-wing authoritarianism appears to have a genetic foundation - PsyPost - April 7th, 2024 [April 7th, 2024]
- UC Irvine-led research team builds first tandem repeat expansions genetic reference maps - UCI News - April 7th, 2024 [April 7th, 2024]
- A Deep Dive Into the Genetics of Alcohol Consumption - University of California San Diego - April 7th, 2024 [April 7th, 2024]
- Untold story of bird evolution revealed through genetics - Earth.com - April 7th, 2024 [April 7th, 2024]
- Genetic Test for Opioid Addiction Risk Should Be Withdrawn, Experts Tell FDA - Medpage Today - April 7th, 2024 [April 7th, 2024]
- Scientists Discover 17 New Genetic Variants Linked to Alzheimer's Disease - SciTechDaily - April 7th, 2024 [April 7th, 2024]
- An hereditary liver disease cured with the help of gene scissors - EurekAlert - April 7th, 2024 [April 7th, 2024]
- World Anthropology Day showcases multifaceted programs | Binghamton News - Binghamton University - April 7th, 2024 [April 7th, 2024]
- Resilience to periodic disturbances and the long-term genetic stability in Acropora coral | Communications Biology - Nature.com - April 7th, 2024 [April 7th, 2024]
- Rare genetic variants found to have a large impact on obesity risk - Drug Target Review - April 7th, 2024 [April 7th, 2024]
- INTERACT COALITION FORMED TO ADVANCE PATIENT ACCESS TO GENETIC TESTING FOR HEREDITARY ... - PR Newswire - April 7th, 2024 [April 7th, 2024]
- Christensen Genetics - AG INFORMATION NETWORK OF THE WEST - AGInfo Ag Information Network - April 7th, 2024 [April 7th, 2024]
- New form of EDS identified by mutation in THBS2 gene - Ehlers-Danlos News - April 7th, 2024 [April 7th, 2024]
- Genetics of estrogen production linked to endometrial cancer risk in postmenopausal women - News-Medical.Net - February 13th, 2024 [February 13th, 2024]
- Cord Blood Registry (CBR) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - PR Newswire - February 13th, 2024 [February 13th, 2024]
- Gene Variant Linked to Lower Levels of Hormonal Birth Control - The Scientist - February 13th, 2024 [February 13th, 2024]
- CooperSurgical, Fulgent partner on genetic screening panels - Medical Device Network - February 13th, 2024 [February 13th, 2024]
- UM Today | Faculty of Science | The intersection of genetics and advocacy - UM Today - February 13th, 2024 [February 13th, 2024]
- Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever - Nature.com - February 13th, 2024 [February 13th, 2024]
- Secrets of human genetics could optimize medical care - Earth.com - February 13th, 2024 [February 13th, 2024]
- Significance of genetic mutations in toxic tort cases - Rhode Island Lawyers Weekly - February 13th, 2024 [February 13th, 2024]
- Why Should Farmers Invest in New Genetics? A Recent Panel Discussion Offered Some Good Reasons - Seed World - February 13th, 2024 [February 13th, 2024]
- The Role of Genetics and Maternal Factors in Retinopathy of Prematurity: A Comparative Study - Medriva - February 13th, 2024 [February 13th, 2024]
- 'The Idea That Who You Are Is Only Genetics Is the Essence of Evil' - Books - Haaretz - February 13th, 2024 [February 13th, 2024]
- IPK researchers provide genetic explanations for shade-induced biomass allocation in wheat - EurekAlert - February 13th, 2024 [February 13th, 2024]
- River Valley Beef Cattle Conference to explore state of hay availability, cattle genetics and more - Stuttgart Daily Leader - February 13th, 2024 [February 13th, 2024]
- Harnessing human evolution to advance precision medicine - EurekAlert - February 13th, 2024 [February 13th, 2024]
- Twins are a mirror to each other and a window into the mysteries of genetics - WAMU 88.5 - February 13th, 2024 [February 13th, 2024]
- Unveiling the Disparity in Cardiovascular Health: Biological Factors, Dyslipidemia, and Genetics - Medriva - February 13th, 2024 [February 13th, 2024]
- Parental traits offer new clues to predicting neurodevelopmental disorders in children - News-Medical.Net - February 13th, 2024 [February 13th, 2024]
- Cheetahs Are Extremely Inbred: 50 Interesting Genetics Facts You May Have Missed At School - Bored Panda - February 4th, 2024 [February 4th, 2024]
- Five Best: Books on Genetics - WSJ - The Wall Street Journal - February 4th, 2024 [February 4th, 2024]
- 4 new US sites added to global Parkinson's genetics study - Parkinson's News Today - February 4th, 2024 [February 4th, 2024]
- Animal Genetics Market revenue to exceed USD 43.4 Billion by 2036, says Research Nester - Yahoo Finance - February 4th, 2024 [February 4th, 2024]
- Nobel Laureate and World-Renowned Geneticist to Speak at 2024 Commencement - News Center - Feinberg News Center - February 4th, 2024 [February 4th, 2024]
- Efforts are underway to improve genetics in cattle herds to better sustainability - RFD-TV - February 4th, 2024 [February 4th, 2024]
- First report on the molecular phylogenetics and population genetics of Aedes aegypti in Iran - Parasites & Vectors - Parasites & Vectors - February 4th, 2024 [February 4th, 2024]
- What can your DNA say about your risk of opioid addiction? - National Geographic - February 4th, 2024 [February 4th, 2024]
- The Born in Guangzhou Cohort Study enables generational genetic discoveries - Nature.com - February 4th, 2024 [February 4th, 2024]
- Rare disorder causing extra fingers and toes identified - EurekAlert - February 4th, 2024 [February 4th, 2024]
- Retinal OCT and Genetics Identify Links Between Ocular and Systemic Health - Photonics.com - February 4th, 2024 [February 4th, 2024]
- Researchers discover mechanism that protects tissue after faulty gene expression - News-Medical.Net - February 4th, 2024 [February 4th, 2024]
- Genetics or lifestyle: What makes the greatest difference in health? - Agweek - February 4th, 2024 [February 4th, 2024]
- Why Some Folks Get COVID, and Others Never Do - HealthDay - February 4th, 2024 [February 4th, 2024]
- From plant genetics to fresh produce to be showcased in Berlin - FreshPlaza.com - February 4th, 2024 [February 4th, 2024]
- Adolescent Stress Alters Brain Genes, Affecting Adult Behavior - Neuroscience News - February 4th, 2024 [February 4th, 2024]
- Significance of genetic mutations in toxic tort cases - Massachusetts Lawyers Weekly - February 4th, 2024 [February 4th, 2024]
- New genetic test in England aims to make blood transfusions safer - Sickle Cell Disease News - February 4th, 2024 [February 4th, 2024]
- Unlocking tree genetic diversity: advanced hyperspectral phenotyping for enhanced Scots pine selection - EurekAlert - January 19th, 2024 [January 19th, 2024]
- The Role of Genetics in Cancer Care Continues to Expand - OncLive - January 19th, 2024 [January 19th, 2024]
- Family faces multiple diagnoses for genetic condition NF1 - Sanford Health News - January 19th, 2024 [January 19th, 2024]
- Unique gene variants tied to glaucoma found in Black patients - Livescience.com - January 19th, 2024 [January 19th, 2024]
- Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics - GlobeNewswire - January 19th, 2024 [January 19th, 2024]